18.78
-1.47%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About M1 Kliniken
Its shares trade on XETRA under the ticker M12.DE. It has been listed since 14 September 2015. In the fiscal year to 31 December 2025, it reported revenue of €364.3m and net income of €22.1m. At that date it held total assets of €189.3m and shareholders' equity of €119.9m.
M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. The company is headquartered in Berlin, Berlin. The company went IPO on 2015-09-14. The firm operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. The company operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 14 Sept 2015
- Employees
- 185
- Website
- m1-kliniken.de ↗
Leadership
Pay as last reported
- Mr. Uwe ZimdarsChairman of the Supervisory Board, since 2017
- Prof. Dr. Dirk HempelDeputy Chairman of the Board, since 2022
- Mr. Attila StraussMember of the Management Board
- Prof. Dr. Sabine MeckMember of the Supervisory Board
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- M1 Kliniken AG has established itself as a leading player in the cosmetic and aesthetic medicine industry. With a strong presence in the German market and expanding internationally, the company enjoys a competitive advantage over its rivals.
- The company possesses exceptional knowledge and technical expertise in the field of cosmetic surgery and non-invasive treatments. This specialization allows M1 Kliniken AG to offer a wide range of high-quality services, attracting a diverse customer base.
- M1 Kliniken AG has successfully developed a reputable brand image associated with professionalism, innovation, and customer satisfaction. The strong brand recognition and positive reputation contribute to customer loyalty and new client acquisitions.
Weaknesses
- The company heavily relies on the German market for its revenue generation. This overreliance may expose M1 Kliniken AG to risks associated with regional economic fluctuations, changes in regulations, or increased competition within Germany.
- M1 Kliniken AG primarily focuses on cosmetic surgeries and non-invasive treatments, which may limit its ability to tap into other lucrative segments of the healthcare industry. Diversifying the product portfolio could enhance the company's growth potential.
Opportunities
- The global demand for cosmetic and aesthetic treatments is steadily increasing, driven by factors such as rising disposable incomes, aging populations, and a growing emphasis on physical appearance. M1 Kliniken AG can capitalize on this trend to expand its customer base and revenue.
- By venturing into international markets, M1 Kliniken AG has an opportunity to tap into new customer segments and diversify its revenue sources. Expanding into countries with emerging economies and a growing middle class can provide a significant growth trajectory for the company.
Threats
- The cosmetic and aesthetic medicine industry is becoming increasingly competitive, with numerous players vying for market share. M1 Kliniken AG must proactively differentiate itself through outstanding customer service, technological advancements, and continuous innovation to stay ahead of its competitors.
- The industry is subject to strict regulations and potential legal challenges, including compliance with medical standards, licensing requirements, and potential malpractice lawsuits. M1 Kliniken AG needs to ensure full compliance and mitigate any legal risks to safeguard its reputation and operations.
- Economic downturns, currency fluctuations, and financial instability can impact consumer spending on aesthetic procedures, potentially decreasing M1 Kliniken AG's demand and revenue. The company should anticipate and proactively address any economic uncertainties that may arise.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.